UBS Group’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Sell |
505,290
-18,872
| -4% | -$62.3K | ﹤0.01% | 3970 |
|
|
2025
Q1 | $1.5M | Sell |
524,162
-9,962
| -2% | -$28.5K | ﹤0.01% | 3896 |
|
|
2024
Q4 | $1.24M | Buy |
534,124
+4,726
| +0.9% | +$11K | ﹤0.01% | 4072 |
|
|
2024
Q3 | $1.67M | Sell |
529,398
-1,142
| -0.2% | -$3.6K | ﹤0.01% | 3186 |
|
|
2024
Q2 | $1.17M | Sell |
530,540
-5,767
| -1% | -$12.7K | ﹤0.01% | 3263 |
|
|
2024
Q1 | $1.67M | Sell |
536,307
-44,271
| -8% | -$138K | ﹤0.01% | 3125 |
|
|
2023
Q4 | $2.25M | Sell |
580,578
-23,861
| -4% | -$92.6K | ﹤0.01% | 2733 |
|
|
2023
Q3 | $1.98M | Sell |
604,439
-29,840
| -5% | -$97.6K | ﹤0.01% | 2551 |
|
|
2023
Q2 | $2.03M | Sell |
634,279
-4,717
| -0.7% | -$15.1K | ﹤0.01% | 2682 |
|
|
2023
Q1 | $2.75M | Buy |
638,996
+16,452
| +3% | +$70.7K | ﹤0.01% | 2309 |
|
|
2022
Q4 | $2.65M | Buy |
622,544
+853
| +0.1% | +$3.63K | ﹤0.01% | 2340 |
|
|
2022
Q3 | $3.06M | Buy |
621,691
+16,285
| +3% | +$80.1K | ﹤0.01% | 2060 |
|
|
2022
Q2 | $1.85M | Buy |
605,406
+6,965
| +1% | +$21.3K | ﹤0.01% | 2444 |
|
|
2022
Q1 | $1.64M | Buy |
598,441
+2,642
| +0.4% | +$7.24K | ﹤0.01% | 2826 |
|
|
2021
Q4 | $1.77M | Buy |
595,799
+13,391
| +2% | +$39.8K | ﹤0.01% | 2963 |
|
|
2021
Q3 | $2.78M | Sell |
582,408
-104,894
| -15% | -$500K | ﹤0.01% | 2501 |
|
|
2021
Q2 | $2.67M | Buy |
687,302
+99,821
| +17% | +$387K | ﹤0.01% | 2501 |
|
|
2021
Q1 | $2.75M | Sell |
587,481
-30,762
| -5% | -$144K | ﹤0.01% | 2477 |
|
|
2020
Q4 | $1.9M | Buy |
618,243
+90,200
| +17% | +$277K | ﹤0.01% | 2671 |
|
|
2020
Q3 | $1.28M | Buy |
528,043
+7,250
| +1% | +$17.6K | ﹤0.01% | 2764 |
|
|
2020
Q2 | $1.59M | Buy |
520,793
+179,148
| +52% | +$548K | ﹤0.01% | 2461 |
|
|
2020
Q1 | $543K | Buy |
341,645
+50,585
| +17% | +$80.4K | ﹤0.01% | 3139 |
|
|
2019
Q4 | $955K | Buy |
291,060
+30,017
| +11% | +$98.5K | ﹤0.01% | 3377 |
|
|
2019
Q3 | $1.04M | Buy |
261,043
+27,300
| +12% | +$109K | ﹤0.01% | 3166 |
|
|
2019
Q2 | $848K | Buy |
233,743
+27,000
| +13% | +$98K | ﹤0.01% | 3162 |
|
|
2019
Q1 | $934K | Buy |
206,743
+38,400
| +23% | +$173K | ﹤0.01% | 2980 |
|
|
2018
Q4 | $663K | Buy |
168,343
+29,550
| +21% | +$116K | ﹤0.01% | 3309 |
|
|
2018
Q3 | $644K | Buy |
138,793
+93,550
| +207% | +$434K | ﹤0.01% | 3477 |
|
|
2018
Q2 | $137K | Buy |
45,243
+38,864
| +609% | +$118K | ﹤0.01% | 4354 |
|
|
2018
Q1 | $24K | Sell |
6,379
-744
| -10% | -$2.8K | ﹤0.01% | 5405 |
|
|
2017
Q4 | $16K | Sell |
7,123
-817
| -10% | -$1.84K | ﹤0.01% | 5744 |
|
|
2017
Q3 | $21K | Buy |
7,940
+513
| +7% | +$1.36K | ﹤0.01% | 5501 |
|
|
2017
Q2 | $9K | Buy |
7,427
+4,112
| +124% | +$4.98K | ﹤0.01% | 5882 |
|
|
2017
Q1 | $10K | Sell |
3,315
-745
| -18% | -$2.25K | ﹤0.01% | 5669 |
|
|
2016
Q4 | $22K | Sell |
4,060
-1,103
| -21% | -$5.98K | ﹤0.01% | 5511 |
|
|
2016
Q3 | $20K | Buy |
5,163
+2,934
| +132% | +$11.4K | ﹤0.01% | 5386 |
|
|
2016
Q2 | $7K | Sell |
2,229
-2,941
| -57% | -$9.24K | ﹤0.01% | 6058 |
|
|
2016
Q1 | $16K | Sell |
5,170
-3,298
| -39% | -$10.2K | ﹤0.01% | 5509 |
|
|
2015
Q4 | $26K | Buy |
8,468
+3,572
| +73% | +$11K | ﹤0.01% | 5311 |
|
|
2015
Q3 | $24K | Buy |
+4,896
| New | +$24K | ﹤0.01% | 5290 |
|